Global Smoking Cessation & Nicotine De-addiction Products Market: By Product Type (Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges) Electronic Cigarette, and Non-nicotine Products (Varenicline, Bupropion, Cytisine)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Retail Stores), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Smoking Cessation & Nicotine De-addiction Products Market Report Description:
Global smoking cessation & nicotine de-addiction products market report gives comprehensive outlook on smoking cessation & nicotine de-addiction products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on smoking cessation & nicotine de-addiction products market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, distribution channel, and geographic regions. This report studies smoking cessation & nicotine de-addiction products market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, smoking cessation & nicotine de-addiction products market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed smoking cessation & nicotine de-addiction products market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the smoking cessation & nicotine de-addiction products market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and prescription of smoking cessation & nicotine de-addiction products.
Global Smoking Cessation & Nicotine De-addiction Products Market:
Global smoking cessation & nicotine de-addiction products market estimated to be valued US$ 9,014 Mn in 2017 and poised to grow at CAGR of 12.7% over 2017-2023. Market for smoking cessation & nicotine de-addiction products projected to reach US$ 18,489 Mn by 2023 owing to growing awareness regarding smoking cessation and availability of wider product choices.
Do policy changes bring positive impact on smoking cessation & nicotine de-addiction products market?
Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. Theses government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandates the tobacco products manufacturers to place warning labels on the products and same laws prohibits the smoking in public areas, these are expected to create market opportunity for the players.
Growing adoption of smoking cessation & nicotine de-addiction products across the globe is creating significant market opportunities
The growing prevalence of smoking and its hazardous effects on cardiac and respiratory system is driving the smokers to adopt alternative to smoking like nicotine based products and E-cigarettes, this is expected to create huge growth opportunity for market players over the forecast period. Moreover, consumers have been exposed to numerous innovative products in different formulations, which are helping buyers to choose appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products, and e-cigarettes are aiding the market revenue growth.
North America emerged as prominent region for smoking cessation & nicotine de-addiction products market across the globe
North America market is expected to hold the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region. Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.
COMPETITION ASSESSMENT
Key players profiles in the global smoking cessation & nicotine de-addiction products market include:
KEY FINDINGS OF THE REPORT:
By Product Type
Global smoking cessation & nicotine de-addiction products market report gives comprehensive outlook on smoking cessation & nicotine de-addiction products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on smoking cessation & nicotine de-addiction products market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, distribution channel, and geographic regions. This report studies smoking cessation & nicotine de-addiction products market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, smoking cessation & nicotine de-addiction products market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed smoking cessation & nicotine de-addiction products market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the smoking cessation & nicotine de-addiction products market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and prescription of smoking cessation & nicotine de-addiction products.
Global Smoking Cessation & Nicotine De-addiction Products Market:
Global smoking cessation & nicotine de-addiction products market estimated to be valued US$ 9,014 Mn in 2017 and poised to grow at CAGR of 12.7% over 2017-2023. Market for smoking cessation & nicotine de-addiction products projected to reach US$ 18,489 Mn by 2023 owing to growing awareness regarding smoking cessation and availability of wider product choices.
Do policy changes bring positive impact on smoking cessation & nicotine de-addiction products market?
Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. Theses government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandates the tobacco products manufacturers to place warning labels on the products and same laws prohibits the smoking in public areas, these are expected to create market opportunity for the players.
Growing adoption of smoking cessation & nicotine de-addiction products across the globe is creating significant market opportunities
The growing prevalence of smoking and its hazardous effects on cardiac and respiratory system is driving the smokers to adopt alternative to smoking like nicotine based products and E-cigarettes, this is expected to create huge growth opportunity for market players over the forecast period. Moreover, consumers have been exposed to numerous innovative products in different formulations, which are helping buyers to choose appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products, and e-cigarettes are aiding the market revenue growth.
North America emerged as prominent region for smoking cessation & nicotine de-addiction products market across the globe
North America market is expected to hold the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region. Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.
COMPETITION ASSESSMENT
Key players profiles in the global smoking cessation & nicotine de-addiction products market include:
- Cipla Ltd. (India)
- GlaxoSmithKline plc. (UK)
- ITC Limited (India)
- Johnson & Johnson Services Inc. (U.S)
- NJOY, Inc. (U.S)
- Novartis AG (Switzerland)
- Pfizer, Inc. (U.S)
- Takeda Pharmaceuticals Co. Ltd. (Japan)
- VMR products, LLC (U.S)
KEY FINDINGS OF THE REPORT:
- Global smoking cessation & nicotine de-addiction products market expanding at 12.7% CAGR over 2017 to 2023 to reach market value of US$ 18,489 Mn by 2023
- Based on product type, nicotine based products segment accounted for larger revenue share in 2016 owing to ease of availability and usability
- Retail stores are prominent source for smoking cessation & nicotine de-addiction products and accounted for larger market revenue share in 2016 expected to remain attractive over the forecast period
- Players are focusing on launching the newer smoking cessation & nicotine de-addiction products in the market and focusing on geographic expansion to gain market revenue share
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Product Type
- Nicotine Based Products
- Nicotine Gums
- Nicotine Patches
- Nicotine Sprays
- Nicotine Inhalers
- Nicotine Lozenges
- Electronic Cigarette
- Non-nicotine Products
- Vareniclin
- Bupropion
- Cytisine
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Retail Stores
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges)
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Electronic Cigarette
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Non-nicotine Products (Vareniclin, Bupropion, and Cytisine)
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FORECAST, BY DISTRIBUTION CHANNEL ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Online Pharmacies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.4. Retail Stores
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.1.1. Nicotine Based Products
8.1.1.1.1. Nicotine Gums
8.1.1.1.2. Nicotine Patches
8.1.1.1.3. Nicotine Sprays
8.1.1.1.4. Nicotine Inhalers
8.1.1.1.5. Nicotine Lozenges
8.1.1.2. Electronic Cigarette
8.1.1.3. Non-nicotine Products
8.1.1.3.1. Vareniclin
8.1.1.3.2. Bupropion
8.1.1.3.3. Cytisine
8.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.2.1. Hospital Pharmacies
8.1.2.2. Retail Pharmacies
8.1.2.3. Online Pharmacies
8.1.2.4. Retail Stores
8.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.3.1. U.S.
8.1.3.2. Canada
8.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.1.1. Nicotine Based Products
8.2.1.1.1. Nicotine Gums
8.2.1.1.2. Nicotine Patches
8.2.1.1.3. Nicotine Sprays
8.2.1.1.4. Nicotine Inhalers
8.2.1.1.5. Nicotine Lozenges
8.2.1.2. Electronic Cigarette
8.2.1.3. Non-nicotine Products
8.2.1.3.1. Vareniclin
8.2.1.3.2. Bupropion
8.2.1.3.3. Cytisine
8.2.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.2.1. Hospital Pharmacies
8.2.2.2. Retail Pharmacies
8.2.2.3. Online Pharmacies
8.2.2.4. Retail Stores
8.2.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.3.1. U.K
8.2.3.2. Germany
8.2.3.3. France
8.2.3.4. Italy
8.2.3.5. Spain
8.2.3.6. Russia
8.2.3.7. Poland 8.2.3.8. Rest of Europe
8.3. Asia-Pacific Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.1.1. Nicotine Based Products
8.3.1.1.1. Nicotine Gums
8.3.1.1.2. Nicotine Patches
8.3.1.1.3. Nicotine Sprays
8.3.1.1.4. Nicotine Inhalers
8.3.1.1.5. Nicotine Lozenges
8.3.1.2. Electronic Cigarette
8.3.1.3. Non-nicotine Products
8.3.1.3.1. Vareniclin
8.3.1.3.2. Bupropion
8.3.1.3.3. Cytisine
8.3.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.2.1. Hospital Pharmacies
8.3.2.2. Retail Pharmacies
8.3.2.3. Online Pharmacies
8.3.2.4. Retail Stores
8.3.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.3.1. Japan
8.3.3.2. China
8.3.3.3. India
8.3.3.4. ASEAN
8.3.3.5. Australia & New Zealand 8.3.3.6. Rest of Asia-Pacific
8.4. Latin America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.1.1. Nicotine Based Products
8.4.1.1.1. Nicotine Gums
8.4.1.1.2. Nicotine Patches
8.4.1.1.3. Nicotine Sprays
8.4.1.1.4. Nicotine Inhalers
8.4.1.1.5. Nicotine Lozenges
8.4.1.2. Electronic Cigarette
8.4.1.3. Non-nicotine Products
8.4.1.3.1. Vareniclin
8.4.1.3.2. Bupropion
8.4.1.3.3. Cytisine
8.4.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.2.1. Hospital Pharmacies
8.4.2.2. Retail Pharmacies
8.4.2.3. Online Pharmacies
8.4.2.4. Retail Stores
8.4.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.3.1. Brazil
8.4.3.2. Mexico
8.4.3.3. Argentina
8.4.3.4. Venezuela
8.4.3.5. Rest of Latin America
8.5. Middle East & Africa (MEA) Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.1.1. Nicotine Based Products
8.5.1.1.1. Nicotine Gums
8.5.1.1.2. Nicotine Patches
8.5.1.1.3. Nicotine Sprays
8.5.1.1.4. Nicotine Inhalers
8.5.1.1.5. Nicotine Lozenges
8.5.1.2. Electronic Cigarette
8.5.1.3. Non-nicotine Products
8.5.1.3.1. Vareniclin
8.5.1.3.2. Bupropion
8.5.1.3.3. Cytisine
8.5.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.2.1. Hospital Pharmacies
8.5.2.2. Retail Pharmacies
8.5.2.3. Online Pharmacies
8.5.2.4. Retail Stores
8.5.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.3.1. Gulf Cooperation Council (GCC) Countries
8.5.3.2. Israel
8.5.3.3. South Africa
8.5.3.4. Rest of MEA
9. COMPETITION LANDSCAPE
9.1. Strategic Dashboard of Top Market Players
9.2. Company Profiles (Introduction, Financial Analysis, Component & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
9.2.1. Cipla Ltd. (India)
9.2.2. GlaxoSmithKline plc. (UK)
9.2.3. ITC Limited (India)
9.2.4. Johnson & Johnson Services Inc. (U.S)
9.2.5. NJOY, Inc. (U.S)
9.2.6. Novartis AG (Switzerland)
9.2.7. Pfizer, Inc. (U.S)
9.2.8. Takeda Pharmaceuticals Co. Ltd. (Japan)
9.2.9. VMR products, LLC (U.S)
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges)
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Electronic Cigarette
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.3. Non-nicotine Products (Vareniclin, Bupropion, and Cytisine)
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FORECAST, BY DISTRIBUTION CHANNEL ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Online Pharmacies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.4. Retail Stores
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.1.1. Nicotine Based Products
8.1.1.1.1. Nicotine Gums
8.1.1.1.2. Nicotine Patches
8.1.1.1.3. Nicotine Sprays
8.1.1.1.4. Nicotine Inhalers
8.1.1.1.5. Nicotine Lozenges
8.1.1.2. Electronic Cigarette
8.1.1.3. Non-nicotine Products
8.1.1.3.1. Vareniclin
8.1.1.3.2. Bupropion
8.1.1.3.3. Cytisine
8.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.2.1. Hospital Pharmacies
8.1.2.2. Retail Pharmacies
8.1.2.3. Online Pharmacies
8.1.2.4. Retail Stores
8.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.3.1. U.S.
8.1.3.2. Canada
8.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.1.1. Nicotine Based Products
8.2.1.1.1. Nicotine Gums
8.2.1.1.2. Nicotine Patches
8.2.1.1.3. Nicotine Sprays
8.2.1.1.4. Nicotine Inhalers
8.2.1.1.5. Nicotine Lozenges
8.2.1.2. Electronic Cigarette
8.2.1.3. Non-nicotine Products
8.2.1.3.1. Vareniclin
8.2.1.3.2. Bupropion
8.2.1.3.3. Cytisine
8.2.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.2.1. Hospital Pharmacies
8.2.2.2. Retail Pharmacies
8.2.2.3. Online Pharmacies
8.2.2.4. Retail Stores
8.2.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.3.1. U.K
8.2.3.2. Germany
8.2.3.3. France
8.2.3.4. Italy
8.2.3.5. Spain
8.2.3.6. Russia
8.2.3.7. Poland 8.2.3.8. Rest of Europe
8.3. Asia-Pacific Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.1.1. Nicotine Based Products
8.3.1.1.1. Nicotine Gums
8.3.1.1.2. Nicotine Patches
8.3.1.1.3. Nicotine Sprays
8.3.1.1.4. Nicotine Inhalers
8.3.1.1.5. Nicotine Lozenges
8.3.1.2. Electronic Cigarette
8.3.1.3. Non-nicotine Products
8.3.1.3.1. Vareniclin
8.3.1.3.2. Bupropion
8.3.1.3.3. Cytisine
8.3.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.2.1. Hospital Pharmacies
8.3.2.2. Retail Pharmacies
8.3.2.3. Online Pharmacies
8.3.2.4. Retail Stores
8.3.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.3.1. Japan
8.3.3.2. China
8.3.3.3. India
8.3.3.4. ASEAN
8.3.3.5. Australia & New Zealand 8.3.3.6. Rest of Asia-Pacific
8.4. Latin America Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.1.1. Nicotine Based Products
8.4.1.1.1. Nicotine Gums
8.4.1.1.2. Nicotine Patches
8.4.1.1.3. Nicotine Sprays
8.4.1.1.4. Nicotine Inhalers
8.4.1.1.5. Nicotine Lozenges
8.4.1.2. Electronic Cigarette
8.4.1.3. Non-nicotine Products
8.4.1.3.1. Vareniclin
8.4.1.3.2. Bupropion
8.4.1.3.3. Cytisine
8.4.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.2.1. Hospital Pharmacies
8.4.2.2. Retail Pharmacies
8.4.2.3. Online Pharmacies
8.4.2.4. Retail Stores
8.4.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.3.1. Brazil
8.4.3.2. Mexico
8.4.3.3. Argentina
8.4.3.4. Venezuela
8.4.3.5. Rest of Latin America
8.5. Middle East & Africa (MEA) Smoking Cessation and Nicotine De-addiction Products Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
8.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.1.1. Nicotine Based Products
8.5.1.1.1. Nicotine Gums
8.5.1.1.2. Nicotine Patches
8.5.1.1.3. Nicotine Sprays
8.5.1.1.4. Nicotine Inhalers
8.5.1.1.5. Nicotine Lozenges
8.5.1.2. Electronic Cigarette
8.5.1.3. Non-nicotine Products
8.5.1.3.1. Vareniclin
8.5.1.3.2. Bupropion
8.5.1.3.3. Cytisine
8.5.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.2.1. Hospital Pharmacies
8.5.2.2. Retail Pharmacies
8.5.2.3. Online Pharmacies
8.5.2.4. Retail Stores
8.5.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.3.1. Gulf Cooperation Council (GCC) Countries
8.5.3.2. Israel
8.5.3.3. South Africa
8.5.3.4. Rest of MEA
9. COMPETITION LANDSCAPE
9.1. Strategic Dashboard of Top Market Players
9.2. Company Profiles (Introduction, Financial Analysis, Component & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
9.2.1. Cipla Ltd. (India)
9.2.2. GlaxoSmithKline plc. (UK)
9.2.3. ITC Limited (India)
9.2.4. Johnson & Johnson Services Inc. (U.S)
9.2.5. NJOY, Inc. (U.S)
9.2.6. Novartis AG (Switzerland)
9.2.7. Pfizer, Inc. (U.S)
9.2.8. Takeda Pharmaceuticals Co. Ltd. (Japan)
9.2.9. VMR products, LLC (U.S)
